ACT-709478
CAY-25371-25 25 mg
Data Sheet: 
SDS:
SDS:
CAS
1838651-58-3
Formulation
A solid
Purity
≥98%
MW
425,406629
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An inhibitor of T-type calcium channels (IC50s = 6.4, 18, and 7.5 nM for Cav3.1, Cav3.2, and Cav3.3, respectively); selective for T-type calcium channels over the L-type calcium channel Cav1.2 (IC50 = 2,410 nM); reduces the cumulative duration of absence-like seizures in rats at 10 mg/kg; reduces seizure severity in a rat model of audiogenic seizures at 100 mg/kg
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
